India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
27/05/2026 07:54
BUZZ-India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop ** Biopharma company Astrazeneca Pharma India's shares ASTR.NS fall as much as 6.76% to 8,357 rupees apiece
** This is stock's steepest intraday decline in two months
** ASTR posts a 23% year-on-year drop in March quarter profit; operating profit slips 29.5%
** Stock is most active in six weeks, with a trading volume of 35,516 shares as of 12:17 p.m. IST, more than quadruple the 30-day average volume, data compiled by LSEG shows
** ASTR shares are down 5.8% in 2026 so far, according to exchange data
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan